<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This paper summarises the guidelines and recommendations that were generated during a number of discussion forums attended by the majority of Belgian cytometry laboratory professionals </plain></SENT>
<SENT sid="1" pm="."><plain>These forums focused on the rational and optimal use of flow cytometric evaluations in the clinical laboratory setting </plain></SENT>
<SENT sid="2" pm="."><plain>The aim was to improve the coherence of the testing panels and the quality of the results and--as such--the clinical diagnostic information </plain></SENT>
<SENT sid="3" pm="."><plain>It was also the aim to provide the Belgian prescribing physician and interested laymen with an updated overview of the flow cytometric possibilities </plain></SENT>
<SENT sid="4" pm="."><plain>Emphasis is placed on immunophenotyping of <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">haematological malignancies</z:e>, hematopoietic progenitor cell counting and follow-up of the <z:mp ids='MP_0001799'>viral</z:mp> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> caused by the human <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> virus </plain></SENT>
</text></document>